Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

InflaRx (IFRX) Invested Capital (2022 - 2024)

Historic Invested Capital for InflaRx (IFRX) over the last 3 years, with Q4 2024 value amounting to $65.6 million.

  • InflaRx's Invested Capital fell 4053.83% to $65.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $65.6 million, marking a year-over-year decrease of 4053.83%. This contributed to the annual value of $66.5 million for FY2024, which is 3977.36% down from last year.
  • According to the latest figures from Q4 2024, InflaRx's Invested Capital is $65.6 million, which was down 4053.83% from $110.4 million recorded in Q4 2023.
  • InflaRx's 5-year Invested Capital high stood at $110.4 million for Q4 2023, and its period low was $139078.0 during Q2 2022.
  • In the last 3 years, InflaRx's Invested Capital had a median value of $32.9 million in 2022 and averaged $44.4 million.
  • In the last 5 years, InflaRx's Invested Capital surged by 2244.72% in 2023 and then plummeted by 4053.83% in 2024.
  • Quarter analysis of 3 years shows InflaRx's Invested Capital stood at $90.1 million in 2022, then grew by 22.45% to $110.4 million in 2023, then plummeted by 40.54% to $65.6 million in 2024.
  • Its Invested Capital was $65.6 million in Q4 2024, compared to $110.4 million in Q4 2023 and $90.1 million in Q4 2022.